BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 15, 2015

View Archived Issues

Sun Pharma announces collaboration to develop recombinant enzyme for stroke and glioblastoma

Read More

AstraZeneca and Wallenberg Centre for Protein Research collaborate to study secretome

Read More

Andes Biotechnologies begins first-in-human study evaluating Andes-1537

Read More

Anti-GDF8 MAb demonstrates efficacy in the treatment of sarcopenia

Read More

ImmBio begins first-in-human studies of PnuBioVax

Read More

Biogen begins phase I/II study of ISIS-SOD1-Rx in patients with ALS

Read More

Adocia and Lilly report phase I results for BioChaperone Lispro U200

Read More

Enrollment open in phase II/III study of TC BioPharm's ImmuniCell

Read More

Kyras Therapeutics launched to develop Ras family inhibitors for cancer

Read More

NeuroQuest extends validation trials of Alzheimer's disease blood test

Read More

Compound based on steroid hormone 20-hydroxyecdysone may improve sarcopenic obesity

Read More

FDA grants orphan drug designation to cromolyn sodium (inhaled) for mastocytosis

Read More

Atara Biotherapeutics reports data from proof-of-concept trial of PINTA-745

Read More

MAT-2501 granted QIDP designation by the FDA

Read More

Flindokalner given FDA orphan drug designation for Fragile X Syndrome

Read More

Horizon Pharma to acquire Crealta

Read More

Tuning T cell affinity improves bispecific antibody efficacy

Read More

New SARM has good safety and efficacy profile in monkeys

Read More

GlaxoSmithKline discloses ROR-gamma modulators

Read More

Cardioxyl Pharmaceuticals and Johns Hopkins University patent nitroxyl donors

Read More

Idenix Pharmaceuticals announces anticancer nucleoside derivatives

Read More

Sage Therapeutics presents GABA-A receptor modulators

Read More

CiRA and Takeda partner to develop clinical applications of induced pluripotent stem cells

Read More

Rebiotix starts clinical trial of RBX-2600 in children with ulcerative colitis

Read More

Akebia Therapeutics and Mitsubishi Tanabe Pharma sign agreement for vadadustat in Asia

Read More

Potassium channel modulator AUT-00206 affects negative symptoms in schizophrenia model

Read More

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing